Results 241 to 250 of about 323,961 (279)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

5 years of the Lancet Regional Health - Europe: science, equity, and why Europe must lead. [PDF]

Lancet Reg Health Eur
The Lancet Regional Health-Europe.
europepmc   +1 more source

Left hemisphere abnormalities in face-selective activation and functional connectivity in developmental prosopagnosia. [PDF]

Imaging Neurosci (Camb)
Campbell A, Li X, Rothlein D, Esterman M, DeGutis J.   +4 more
europepmc   +1 more source

Situating genetic counseling research: The role of the sociopolitical climate in research production and interpretation. [PDF]

J Genet Couns
Zayhowski K, Diaz Caro D, Valentine R, Austin JJ.   +3 more
europepmc   +1 more source

Trumped

@SeAMK, 2018
openaire   +2 more sources

Immigration policy as public health policy: Trump's first administration and a critical public health response to the second. [PDF]

Front Public Health
Calhoon CM, Alang SM.
europepmc   +1 more source